Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 52-58

  Kuhn, Louise ^a   Steketee, Richard W ^b   Weedon, Jeremy ^b   Abrams, Elaine J ^b   Lambert, Genevieve ^b   Bamji, Marukh ^b   Schoenbaum, Ellie ^b   Farley, John ^b   Nesheim, Steve R ^b   Palumbo, Paul ^b   Simonds, R J ^b   Thea, Donald M ^b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAUTERINE INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEMBRANE RUPTURE; NEWBORN; POLYMERASE CHAIN REACTION; PREDICTION; PREGNANCY; PREMATURE LABOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; VIRUS CULTURE; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RISK FACTORS; TIME FACTORS; ZIDOVUDINE;

EID: 0032929576     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314551     Document Type: Article

References (32)

1. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992;327:1246-7.
2. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995;9:F7-11.
3. Laure F, Courgnaud V, Rouzioux C, et al. Detection of HIV-1 DNA in infants and children by means of the polymerase chain reaction. Lancet 1988;2:538-41.
4. Ehrnst A, Lindgren S, Dictor M, et al. HIV in pregnant women and their offspring: evidence for late transmission. Lancet 1991;338:203-7.
5. Rogers MF, Ou CY, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med 1989;320:1649-54.
6. Comeau AM, Hsu HW, Schwerzler M, et al. Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards. J Pediatr 1993;123:252-8.
7. Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. Lancet 1992;339:1187-9.
8. Burgard M, Mayaux MJ, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992;327:1192-7.
9. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. JAMA 1996;275:606-10.
10. Dickover RE, Dillon M, Gillette SG, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994;170:1279-84.
11. Kalish LA, Pitt J, Lew J, et al. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. J Infect Dis 1997;175:712-5.
12. Chouquet C, Burgard M, Richardson S, Rouzioux C, Costagliola D. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS 1997;11:1183-4.
13. Kuhn L, Abrams EJ, Chinchilla M, Tsai WY, Thea DM. Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period. AIDS 1996;10:1181-2.
14. Blanche S, Mayaux MJ, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994;330:308-12.
15. Abrams EJ, Matheson PB, Thomas PA, et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995;96:451-8.
16. Kuhn L, Abrams EJ, Matheson PB, et al. Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997;11:429-35.
17. Levy JA, Shimabukuro J. Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. J Infect Dis 1985;152:734-8.
18. Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of human immunodeficiency virus. AIDS 1998;12:301-8.
19. Nesheim SR, Shaffer N, Vink P, et al. Lack of increased risk for perinatal human immunodeficiency virus transmission to subsequent children born to infected women. Pediatr Infect Dis J 1996;15:886-90.
20. Rouzioux C, Costagliola D, Burgard M, et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995;142:1330-7.
21. + lymphocytes in HIV-exposed infants with early positive HIV cultures: a possible early marker of intrauterine transmission. Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:204-10.
22. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43(RR-11):1-20.
23. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996;334:1617-23.
24. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996;175:661-7.
25. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
26. Goedert JJ, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet 1989;2:1351-4.
27. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996;347:1647-50.
28. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57-62.
29. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-7.
30. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997;336:1337-42.
31. Abrams EJ, Weedon J, Steketee RW, et al. Association of human immuno-deficiency virus (HIV) load early in life with disease progression among HIV-infected infants. J Infect Dis 1998;178:101-8.
32. De Rossi A, Giaquinto C, Ometto L, et al. Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 1993;123:929-36.